🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
100 Servings
Fat/Fatty Acid Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Fat
1 Gram(s) (1.5% DV)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 1000mg UL 3000mg

Other Ingredients

Gelatin Glycerin Water, Purified Vitamin E

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Directions: As a dietary supplement for adults, take 1 softgel up to 2 times daily with meals or as directed by a healthcare professional.

⚠️ Warnings & Precautions

Contains: Fish (Anchovy)

Warning: Do not use if you are pregnant or nursing.

Keep out of reach of children.

🧪 Formulation Notes

Futurebiotics Omega-3 Fish Oil supplies the Omega-3 fatty acids Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA).

The fish oil used in Futurebiotics Omega-3 is molecularly distilled to ensure the oil is free from environmental contaminants.

Omega-3 fatty acids are considered one of the "good" fats that research has shown are important for nutritionally supporting heart health.

Each Futurebiotics Omega-3 softgel supplies 1000 mg fish oil, which provides 180 mg of EPA and 120 mg of DHA.

Provides EPA and DHA

Nutritionally supports heart health Molecularly distilled for purity

Additional Information

100% Satisfaction guaranteed Health. Nature. Life.

Protect from light.

Product Details

UPC / SKU 0 49479 00955 8
DSLD Entry Date 2022-01-22
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 259169
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →